Refining the phenotype associated with GNB1 mutations: Clinical data on 18 newly identified patients and review of the literature

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Hemati, P
  • Revah-Politi, A
  • Bassan, H
  • Petrovski, S
  • Bilancia, CG
  • Ramsey, K
  • Griffin, NG
  • Bier, L
  • Cho, MT
  • Lynch, SA
  • Colombo, S
  • Weber, A
  • Haug, M
  • Heinzen, EL
  • Sands, TT
  • Narayanan, V
  • Primiano, M
  • Aggarwal, VS
  • Millan, F
  • Sattler-Holtrop, SG
  • Pillar, N
  • Baker, J
  • Freedman, R
  • Kroes, HY
  • Sacharow, S
  • Stong, N
  • Lapunzina, P
  • Schneider, MC
  • Mendelsohn, NJ
  • Singleton, A
  • Ramey, VL
  • Wou, K
  • Kuzminsky, A
  • Weiss, M
  • Doyle, S
  • Iglesias, A
  • Mckenzie, F
  • van Gassen, KLI
  • Palomares, M
  • Bazak, L
  • Lee, A
  • Bircher, A
  • Basel-Vanagaite, L
  • Hafstrom, M
  • Houge, G
  • Goldstein, DB
  • Anyane-Yeboa, K
  • C4RCD Res Grp
  • DDD Study

Grupos

Abstract

De novo germline mutations in GNB1 have been associated with a neurodevelopmental phenotype. To date, 28 patients with variants classified as pathogenic have been reported. We add 18 patients with de novo mutations to this cohort, including a patient with mosaicism for a GNB1 mutation who presented with a milder phenotype. Consistent with previous reports, developmental delay in these patients was moderate to severe, and more than half of the patients were non-ambulatory and nonverbal. The most observed substitution affects the p.Ile80 residue encoded in exon 6, with 28% of patients carrying a variant at this residue. Dystonia and growth delay were observed more frequently in patients carrying variants in this residue, suggesting a potential genotype-phenotype correlation. In the new cohort of 18 patients, 50% of males had genitourinary anomalies and 61% of patients had gastrointestinal anomalies, suggesting a possible association of these findings with variants in GNB1. In addition, cutaneous mastocytosis, reported once before in a patient with a GNB1 variant, was observed in three additional patients, providing further evidence for an association to GNB1. We will review clinical and molecular data of these new cases and all previously reported cases to further define the phenotype and establish possible genotype-phenotype correlations.

Datos de la publicación

ISSN/ISSNe:
1552-4825, 1552-4833

AMERICAN JOURNAL OF MEDICAL GENETICS PART A  WILEY-BLACKWELL

Tipo:
Article
Páginas:
2259-2275
Factor de Impacto:
1,114 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 34

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • developmental disabilities; GNB1; hypotonia; mastocytosis; seizures; whole exome sequencing

Proyectos asociados

RED DE BIOBANCOS (BIOBANCOS)

RD09/0076/00021 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010

COMPREHENSIVE, INTEGRATIVE AND GENOMIC APPROACH TO THE UNDERSTANDING AND TREATMENT OF CANCER AND LEUKEMIA.

Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO

PIE13/00046 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

LA RUTA DE LA OXITOCINA EN LOS TRASTORNOS DEL ESPECTRO AUTISTA: IMPORTANCIA DE LAS VARIANTES GENÉTICAS CON RELEVANCIA FUNCIONAL.

Investigador Principal: CARMEN ORELLANA ALONSO

2014_0056_CRC_ORELLANA . 2014

ABORDAJE GENÓMICO PARA LA IDENTIFICACIÓN DE NUEVOS GENES Y MÓDULOS FUNCIONALES RESPONSABLES DE DISCAPACIDAD INTELECTUAL GRAVE.

Investigador Principal: FRANCISCO MARTÍNEZ CASTELLANO

PI14/00350 . INSTITUTO DE SALUD CARLOS III . 2015

NUEVA APROXIMACIÓN GENÓMICA PARA EL DIAGNÓSTICO DE AUTISMO Y DISCAPACIDAD INTELECTUAL: IMPORTANCIA DE LAS MUTACIONES ADQUIRIDAS EN MOSAICISMO SOMÁTICO Y DE NUEVOS GENES CANDIDATOS.

Investigador Principal: SANDRA MONFORT MEMBRADO

2018_0170_CRC_MUTUA MADRILEÑA_MONFORT . FUNDACION MUTUA MADRILEÑA . 2018

Cita

Compartir